Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Multiple Myeloma
Mechanism of Action
BCMAxCD3 Bispecific
Clinical Trial
NCT03761108Last updated: 12/3/2025
REGN
Regeneron Pharmaceuticals, Inc.